Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
November 21, 2019 07:00 ET
|
Immuron Limited
Key Points Immuron completes first meeting with FDA on development of IMM-124E as product to specifically prevent Travelers’ Diarrhea (TD)Phase 3 clinical trial of IMM-124E to prevent TD planned for...